Trifluoroacetic acid → HCID 22629192, compound
Reaction equation
C(OC([N:8]1[CH2:13][CH2:12][C:11](=[O:14])[CH:10]([N:15]2[C:20](=[O:21])[CH:19]=[CH:18][C:17]([C:22]3[C:23]([C:31]4[CH:36]=[CH:35][CH:34]=[CH:33][CH:32]=4)=[N:24][N:25]4[CH:30]=[CH:29][CH:28]=[CH:27][C:26]=34)=[N:16]2)[CH2:9]1)=O)(C)(C)C.FC(F)(F)C(O)=O>ClCCl.CO>[O:14]=[C:11]1[CH2:12][CH2:13][NH:8][CH2:9][CH:10]1[N:15]1[C:20](=[O:21])[CH:19]=[CH:18][C:17]([C:22]2[C:23]([C:31]3[CH:36]=[CH:35][CH:34]=[CH:33][CH:32]=3)=[N:24][N:25]3[CH:30]=[CH:29][CH:28]=[CH:27][C:26]=23)=[N:16]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of 3-[2-(1-tert-butoxycarbonyl-4-oxopiperidin-3-yl)-3-oxo-2,3-dihydropyridazin-6-yl]-2-phenylpyrazolo[1,5-a]pyridine (500 mg) in dichloromethane (10 ml) was added trifluoroacetic acid (5 ml) at room temperature, and stirred for 2 hours. Solvent was evaporated and removed by toluene azeotrope to give residue, which was chromatographed on silica gel eluting in turn with 5% and 10% methanol in dichloromethane. Fractions containing desired product were collected and concentrated in vacuo to give residue, which was dissolved in methanol and passed through Amberlite IRA-910 (10ml). eluting with methanol. Solvent was removed under reduced pressure to give 3-[2-(4-oxopiperidin-3-yl)-3-oxo-2,3-dihydropyridazin-6-yl]-2-phenylpyrazolo[1,5-a]pyridine (0.3 g).
Workup
- customSolvent was evaporated
- customremoved by toluene azeotrope
- customto give residue, which
- customwas chromatographed on silica gel eluting in turn with 5% and 10% methanol in dichloromethane
- additionFractions containing desired product
- customwere collected
- concentrationconcentrated in vacuo
- customto give residue, which
- washeluting with methanol
- customSolvent was removed under reduced pressure
Sources & evidence
- ORD record
- ord-744db13d864142c4a378e1b927557f02
- Source dataset
- uspto-grants-2002_03
- Patent number
- US06355640B1
Reaction notes
Loading…